🔎 Trials Near Me

Hjem › Overvægt › Indiana › Indianapolis

Overvægt kliniske forsøg i Indianapolis, IN

20 studier for Overvægt søger deltagere på steder i og omkring Indianapolis (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

RekruttererFase 2
  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

RekruttererFase 3
  • IU Health - Riley Physicians Endo-Diab, Indianapolis
Alder 8 til 18 · Alle køn · Opdateret 30. sep. 2026 · NCT07253285

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

RekruttererFase 3
  • Midwest Inst For Clin Res, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

RekruttererFase 3
  • Midwest Inst For Clin Res, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07668414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekruttererFase 3
  • Indiana University Health University Hospital, Indianapolis
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RekruttererFase 3
  • Riley Hospital for Children, Indianapolis
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RekruttererFase 3
  • Indiana University Health University Hospital, Indianapolis
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

RekruttererFase 3
  • Midwest Inst For Clin Res, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • DM Clinical Research - Indianapolis, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 3
  • AURORA-1 Clinical Site, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RekruttererFase 3
  • AURORA-2 Clinical Site, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

RekruttererFase 3
  • Ascension Medical Group, Indianapolis
Alder 18 til 99 · Alle køn · Opdateret 16. sep. 2026 · NCT07037459

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

RekruttererFase 2
  • Investigators Research Group, Brownsburg · 14 mi væk
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT06897475

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

RekruttererFase 4
  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
  • The Indiana Clinical Trials Center, PC, Plainfield · 14 mi væk
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06857942

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

RekruttererFase 3
  • Midwest Inst For Clin Res, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07745504

The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action

RekruttererFase 2
  • Indiana University School of Medicine, Indianapolis
Alder 11 til 18 · Alle køn · Opdateret 21. aug. 2026 · NCT05414409

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

RekruttererFase 3
  • Indiana University Health Methodist Hospital, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07567001

A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents

RekruttererFrivillige med god helbredstilstand velkomne
  • Indiana University Hospital, Indianapolis
Alder 12 til 18 · Alle køn · Opdateret 6. aug. 2026 · NCT07223151

Fibrosis Lessens After Metabolic Surgery

RekruttererFase 4Frivillige med god helbredstilstand velkomne
  • Indiana University, Indianapolis
Alder 18 til 75 · Alle køn · Opdateret 31. jul. 2026 · NCT06374875

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Rekrutterer
  • Indiana University, Indianapolis
Alder 18 til 45 · Kvinder · Opdateret 24. jun. 2026 · NCT05124808

Overvægt forsøg i andre byer

Andre studier i Indianapolis

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.